Detailed Mechanism Funding and Narrative

Years of mechanism: 2013 2014 2015 2016 2017 2018

Details for Mechanism ID: 16583
Country/Region: South Africa
Year: 2016
Main Partner: Aurum Institute
Main Partner Program: NA
Organizational Type: NGO
Funding Agency: HHS/CDC
Total Funding: $1,107,437 Additional Pipeline Funding: $8,684,551

NOTE: PEPFAR no longer creates activity narratives for each mechanism. In their place, PEPFAR has begun releasing mechanism specific targets that reveal the achievements and programs that are expected of the funding. If available for this mechanism, these targets are presented below.

Mechanism Allocation by Budget Code for Selected Year
Care: Adult Care and Support (HBHC) $0
Care: Orphans and Vulnerable Children (HKID) $1,107,437
Care: TB/HIV (HVTB) $0
Care: Pediatric Care and Support (PDCS) $0
Laboratory Infrastructure (HLAB) $0
Health Systems Strengthening (OHSS) $0
Biomedical Prevention: Prevention of Mother to Child Transmission (MTCT) $0
Treatment: Adult Treatment (HTXS) $0
Treatment: Pediatric Treatment (PDTX) $0
Mechanism Target Information

Since COP2014, PEPFAR no longer produces narratives for every mechanism it funds. However, PEPFAR has now included performance targets or indicator information for each mechanism based on the Monitoring, Evaluation, and Reporting (MER) system. The MER guidance is available on PEPFAR's website https://www.pepfar.gov/reports/guidance/. Note that COP years 2014-2015 were under a previous version of the MER system and the indicators and definitions may have changed as of the new 2.0 guidance.

MER Indicator MER description Target Fiscal Year Target
HTS_TST Age/sex: <1 2017 1,694
HTS_TST Age/sex: 1-9 2017 1,694
HTS_TST Age/sex: 15-19 Female 2017 3,395
HTS_TST Age/sex: 20-24 Female 2017 15,332
HTS_TST Age/sex: 20-24 Male 2017 2,644
HTS_TST Age/sex: 25-49 Female 2017 81,404
HTS_TST Age/sex: 25-49 Male 2017 44,352
HTS_TST Age/sex: 50+ Female 2017 8,459
HTS_TST Age/sex: 50+ Male 2017 8,456
HTS_TST Aggregated Age/sex - USE WITH HQ PERMISSION ONLY: <15 Female 2017 12,830
HTS_TST Aggregated Age/sex - USE WITH HQ PERMISSION ONLY: <15 Male 2017 12,830
HTS_TST Aggregated Age/sex - USE WITH HQ PERMISSION ONLY: 15+ Female 2017 243,660
HTS_TST Aggregated Age/sex - USE WITH HQ PERMISSION ONLY: 15+ Male 2017 158,145
HTS_TST Number of individuals who received T&C services for HIV and received their test results during the past 12 months 2017 427,473
HTS_TST Service Delivery Point (Facility): PMTCT 2017 62,312
HTS_TST Service Delivery Point (Facility): VCT 2017 360,827
HTS_TST Service Delivery Point (Facility): VMMC 2017 426
HTS_TST Sum of Age/Sex disaggregates 2017 164,042
HTS_TST Sum of Aggregated Age/Sex <15 2017 25,660
HTS_TST Sum of Aggregated Age/Sex 15+ 2017 401,805
HTS_TST Sum of Aggregated Age/Sex disaggregates 2017 427,465
HTS_TST_POS Test Result by Age and Sex: Positive: 15-19 Female 2017 579
HTS_TST_POS Test Result by Age and Sex: Positive: 20-24 Female 2017 2,595
HTS_TST_POS Test Result by Age and Sex: Positive: 20-24 Male 2017 474
HTS_TST_POS Test Result by Age and Sex: Positive: 25-49 Female 2017 13,566
HTS_TST_POS Test Result by Age and Sex: Positive: 25-49 Male 2017 7,796
HTS_TST_POS Test Result by Age and Sex: Positive: 50+ Female 2017 1,439
HTS_TST_POS Test Result by Age and Sex: Positive: 50+ Male 2017 1,438
HTS_TST_POS Test Result by Age: Positive: <1 2017 287
HTS_TST_POS Test Result by Age: Positive: 1-9 2017 285
HTS_TST_POS Test Result by Aggregated Age and Sex: Positive <15 Female 2017 1,671
HTS_TST_POS Test Result by Aggregated Age and Sex: Positive <15 Male 2017 1,666
HTS_TST_POS Test Result by Aggregated Age and Sex: Positive 15+ Female 2017 31,668
HTS_TST_POS Test Result by Aggregated Age and Sex: Positive 15+ Male 2017 20,559
OVC_SERV Age/Sex: 18+ Female 2017 1,975
OVC_SERV Age/Sex: 18+ Female 2017 2,407
OVC_SERV Age/Sex: 18+ Male 2017 520
OVC_SERV Age/Sex: 18+ Male 2017 632
OVC_SERV By Aggregated Age/Sex: <18 Female 2017 4,263
OVC_SERV By Aggregated Age/Sex: <18 Male 2017 3,639
OVC_SERV Number of active beneficiaries served by PEPFAR OVC programs for children and families affected by HIV/AIDS 2017 10,396
OVC_SERV Number of active beneficiaries served by PEPFAR OVC programs for children and families affected by HIV/AIDS 2017 12,666
OVC_SERV Sum of Age/Sex disaggregates 2017 2,495
OVC_SERV Sum of Age/Sex disaggregates 2017 3,039
PMTCT_ART Already on ART at beginning of current pregnancy 2017 6,504
PMTCT_ART New on ART 2017 15,175
PMTCT_ART Number of pregnant women with known HIV status (includes women who were tested for HIV and received their results) 2017 96,234
PMTCT_EID By infants who received a virologic test within 2 months of birth 2017 21,671
PMTCT_EID By infants who received their first virologic HIV test between 2 and 12 months of age 2017 33
PMTCT_EID Number of infants with a positive virological test result within 2 months of birth 2017 317
PMTCT_EID Sum of Infant Age disaggregates 2017 21,704
PMTCT_STAT By Age (DREAMS SNUs ONLY): <15 2017 615
PMTCT_STAT By Age (DREAMS SNUs ONLY): 15-19 2017 3,716
PMTCT_STAT By Age (DREAMS SNUs ONLY): 20-24 2017 14,715
PMTCT_STAT By Age (DREAMS SNUs ONLY): 25-49 2017 42,458
PMTCT_STAT By: Known positives at entry 2017 11,033
PMTCT_STAT By: Number of new positives identified 2017 16,633
PMTCT_STAT Number of new ANC and L&D clients 2017 98,195
PMTCT_STAT Number of pregnant women with known HIV status (includes women who were tested for HIV and received their results) 2017 96,234
PMTCT_STAT Required only for DREAMS countries - By known positives: <15 2017 78
PMTCT_STAT Required only for DREAMS countries - By known positives: 15-19 2017 465
PMTCT_STAT Required only for DREAMS countries - By known positives: 20-24 2017 1,817
PMTCT_STAT Required only for DREAMS countries - By known positives: 25-49 2017 5,485
PMTCT_STAT Required only for DREAMS countries - By known positives: 50+ 2017 64
PMTCT_STAT Required only for DREAMS countries - By new positives: <15 2017 111
PMTCT_STAT Required only for DREAMS countries - By new positives: 15-19 2017 677
PMTCT_STAT Required only for DREAMS countries - By new positives: 20-24 2017 3,120
PMTCT_STAT Required only for DREAMS countries - By new positives: 25-49 2017 7,859
PMTCT_STAT Required only for DREAMS countries - By new positives: 50+ 2017 5
PMTCT_STAT Sum of Positives Status disaggregates 2017 27,666
PP_PREV Aggregated Age/sex: <15 Female 2017 293
PP_PREV Aggregated Age/sex: <15 Male 2017 293
PP_PREV Aggregated Age/sex: 15+ Female 2017 1,171
PP_PREV Aggregated Age/sex: 15+ Male 2017 1,818
PP_PREV Number of the target population who completed a standardized HIV prevention intervention including the minimum components during the reporting period 2017 3,573
TB_ART Aggregated Age/Sex: Female <15 (Numerator: The number of registered new and relapse TB cases with documented HIV-positive status who are on ART during TB treatment during the reporting period) 2017 320
TB_ART Aggregated Age/Sex: Female 15+ (Numerator: The number of registered new and relapse TB cases with documented HIV-positive status who are on ART during TB treatment during the reporting period) 2017 6,045
TB_ART Aggregated Age/Sex: Male <15 (Numerator: The number of registered new and relapse TB cases with documented HIV-positive status who are on ART during TB treatment during the reporting period) 2017 320
TB_ART Aggregated Age/Sex: Male 15+ (Numerator: The number of registered new and relapse TB cases with documented HIV-positive status who are on ART during TB treatment during the reporting period) 2017 3,919
TB_ART The number of registered new and relapse TB cases with documented HIV-positive status during TB treatment during the reporting period 2017 11,607
TB_ART The number of registered new and relapse TB cases with documented HIV-positive status who are on ART during TB treatment during the reporting period 2017 10,557
TB_SCREENDX Screen Results: Screened Positive for TB 2017 2,060
TB_SCREENDX Screened for TB by Age/Sex: <15 Female 2017 16,841
TB_SCREENDX Screened for TB by Age/Sex: <15 Male 2017 16,841
TB_SCREENDX Screened for TB by Age/Sex: 15+ Female 2017 320,114
TB_SCREENDX Screened for TB by Age/Sex: 15+ Male 2017 207,787
TB_SCREENDX The number of PLHIV who were screened for TB symptoms at the last clinical visit at a HIV facility during the reporting period 2017 561,572
TB_STAT Aggregated Age/Sex: Female <15 (Numerator: Number of registered new and relapsed TB cases with documented HIV status, during the reporting period) 2017 579
TB_STAT Aggregated Age/Sex: Female 15+ (Numerator: Number of registered new and relapsed TB cases with documented HIV status, during the reporting period) 2017 10,983
TB_STAT Aggregated Age/Sex: Male <15 (Numerator: Number of registered new and relapsed TB cases with documented HIV status, during the reporting period) 2017 579
TB_STAT Aggregated Age/Sex: Male 15+ (Numerator: Number of registered new and relapsed TB cases with documented HIV status, during the reporting period) 2017 7,266
TB_STAT Number of registered new and relapsed TB cases with documented HIV status, during the reporting period 2017 19,391
TB_STAT Total number of registered new and relapsed TB cases, during the reporting period 2017 20,337
TX_CURR Age/Sex: <1 2017 3,067
TX_CURR Age/Sex: 1-9 2017 3,464
TX_CURR Age/Sex: 15-19 Female 2017 6,537
TX_CURR Age/Sex: 20-24 Female 2017 29,532
TX_CURR Age/Sex: 20-24 Male 2017 5,983
TX_CURR Age/Sex: 25-49 Female 2017 154,799
TX_CURR Age/Sex: 25-49 Male 2017 87,366
TX_CURR Age/Sex: 50+ Female 2017 16,233
TX_CURR Age/Sex: 50+ Male 2017 16,337
TX_CURR Aggregated Age/Sex: <15 Female 2017 16,224
TX_CURR Aggregated Age/Sex: <15 Male 2017 16,229
TX_CURR Aggregated Age/Sex: 15+ Female 2017 306,100
TX_CURR Aggregated Age/Sex: 15+ Male 2017 210,372
TX_CURR Number of adults and children receiving antiretroviral therapy (ART) 2017 542,101
TX_CURR Sum of Age/Sex disaggregations 2017 6,537
TX_CURR Sum of Aggregated Age/Sex <15 2017 32,453
TX_CURR Sum of Aggregated Age/Sex 15+ 2017 516,472
TX_CURR Sum of Aggregated Age/Sex disaggregates 2017 548,925
TX_NEW Aggregated Grouping by Age: <1 2017 466
TX_NEW Aggregated Grouping by Age/Sex: <15 Female 2017 3,229
TX_NEW Aggregated Grouping by Age/Sex: <15 Male 2017 3,229
TX_NEW Aggregated Grouping by Age/Sex: 15+ Female 2017 61,340
TX_NEW Aggregated Grouping by Age/Sex: 15+ Male 2017 39,810
TX_NEW By Age/Sex: 1-9 2017 596
TX_NEW By Age/Sex: 15-19 Female 2017 1,031
TX_NEW By Age/Sex: 20-24 Female 2017 4,659
TX_NEW By Age/Sex: 20-24 Male 2017 896
TX_NEW By Age/Sex: 25-49 Female 2017 25,371
TX_NEW By Age/Sex: 25-49 Male 2017 14,210
TX_NEW By Age/Sex: 50+ Female 2017 2,589
TX_NEW By Age/Sex: 50+ Male 2017 2,586
TX_NEW Number of adults and children newly enrolled on antiretroviral therapy (ART) 2017 107,593
TX_NEW Sum of Age/Sex disaggregates 2017 51,342
TX_NEW Sum of Aggregated Age/Sex disaggregates 2017 107,608
TX_PVLS Number of adult and pediatric ART patients with a viral load result documented in the patient medical record and /or laboratory records in the past 12 months 2017 490,045
TX_PVLS Number of adults and pediatric patients on ART with suppressed viral load results (<1,000 copies/ml) documented in the medical records and /or supporting laboratory results within the past 12 months 2017 441,039
TX_PVLS Numerator Aggregated Age/Sex: <15 Female 2017 13,020
TX_PVLS Numerator Aggregated Age/Sex: <15 Male 2017 13,020
TX_PVLS Numerator Aggregated Age/Sex: 15+ Female 2017 246,312
TX_PVLS Numerator Aggregated Age/Sex: 15+ Male 2017 167,434
TX_PVLS_den Denominator Aggregated Age/Sex: <15 Female 2017 14,462
TX_PVLS_den Denominator Aggregated Age/Sex: <15 Male 2017 14,462
TX_PVLS_den Denominator Aggregated Age/Sex: 15+ Female 2017 273,765
TX_PVLS_den Denominator Aggregated Age/Sex: 15+ Male 2017 187,361
TX_RET Age/Sex: <1 (Numerator: Number of adults and children who are still alive and on treatment at 12 months after initiating ART) 2017 1,838
TX_RET Age/Sex: 1-9 (Numerator: Number of adults and children who are still alive and on treatment at 12 months after initiating ART) 2017 1,820
TX_RET Age/Sex: 10-14 Female (Numerator: Number of adults and children who are still alive and on treatment at 12 months after initiating ART) 2017 9
TX_RET Age/Sex: 15-19 Female (Numerator: Number of adults and children who are still alive and on treatment at 12 months after initiating ART) 2017 3,656
TX_RET Age/Sex: 20-24 Female (Numerator: Number of adults and children who are still alive and on treatment at 12 months after initiating ART) 2017 16,464
TX_RET Age/Sex: 20-24 Male (Numerator: Number of adults and children who are still alive and on treatment at 12 months after initiating ART) 2017 2,118
TX_RET Age/Sex: 25-49 Female (Numerator: Number of adults and children who are still alive and on treatment at 12 months after initiating ART) 2017 87,798
TX_RET Age/Sex: 25-49 Male (Numerator: Number of adults and children who are still alive and on treatment at 12 months after initiating ART) 2017 49,177
TX_RET Age/Sex: 50+ Female (Numerator: Number of adults and children who are still alive and on treatment at 12 months after initiating ART) 2017 9,148
TX_RET Age/Sex: 50+ Male (Numerator: Number of adults and children who are still alive and on treatment at 12 months after initiating ART) 2017 9,048
TX_RET Aggregated Age/Sex: <15 Female (Numerator: Number of adults and children who are still alive and on treatment at 12 months after initiating ART) 2017 8,452
TX_RET Aggregated Age/Sex: <15 Male (Numerator: Number of adults and children who are still alive and on treatment at 12 months after initiating ART) 2017 8,455
TX_RET Aggregated Age/Sex: 15+ Female (Numerator: Number of adults and children who are still alive and on treatment at 12 months after initiating ART) 2017 159,113
TX_RET Aggregated Age/Sex: 15+ Male (Numerator: Number of adults and children who are still alive and on treatment at 12 months after initiating ART) 2017 104,125
TX_RET Number of adults and children who are still alive and on treatment at 12 months after initiating ART 2017 280,168
TX_RET Total number of adults and children who initiated ART in the 12 months prior to the beginning of the reporting period, including those who have died, those who have stopped ART, and those lost to follow-up 2017 298,053
TX_RET_den Age/Sex: <1 (Denominator: Total number of adults and children who initiated ART in the 12 months prior to the beginning of the reporting period, including those who have died, those who have stopped ART, and those lost to follow-up) 2017 1,946
TX_RET_den Age/Sex: 1-9 (Denominator: Total number of adults and children who initiated ART in the 12 months prior to the beginning of the reporting period, including those who have died, those who have stopped ART, and those lost to follow-up) 2017 1,946
TX_RET_den Age/Sex: 15-19 Female (Denominator: Total number of adults and children who initiated ART in the 12 months prior to the beginning of the reporting period, including those who have died, those who have stopped ART, and those lost to follow-up) 2017 3,904
TX_RET_den Age/Sex: 20-24 Female (Denominator: Total number of adults and children who initiated ART in the 12 months prior to the beginning of the reporting period, including those who have died, those who have stopped ART, and those lost to follow-up) 2017 17,504
TX_RET_den Age/Sex: 20-24 Male (Denominator: Total number of adults and children who initiated ART in the 12 months prior to the beginning of the reporting period, including those who have died, those who have stopped ART, and those lost to follow-up) 2017 1,965
TX_RET_den Age/Sex: 25-49 Female (Denominator: Total number of adults and children who initiated ART in the 12 months prior to the beginning of the reporting period, including those who have died, those who have stopped ART, and those lost to follow-up) 2017 93,676
TX_RET_den Age/Sex: 25-49 Male (Denominator: Total number of adults and children who initiated ART in the 12 months prior to the beginning of the reporting period, including those who have died, those who have stopped ART, and those lost to follow-up) 2017 51,886
TX_RET_den Age/Sex: 50+ Female (Denominator: Total number of adults and children who initiated ART in the 12 months prior to the beginning of the reporting period, including those who have died, those who have stopped ART, and those lost to follow-up) 2017 9,695
TX_RET_den Age/Sex: 50+ Male (Denominator: Total number of adults and children who initiated ART in the 12 months prior to the beginning of the reporting period, including those who have died, those who have stopped ART, and those lost to follow-up) 2017 10,112
TX_RET_den Aggregated Age/Sex: <15 Female (Denominator: Total number of adults and children who initiated ART in the 12 months prior to the beginning of the reporting period, including those who have died, those who have stopped ART, and those lost to follow-up) 2017 8,963
TX_RET_den Aggregated Age/Sex: <15 Male (Denominator: Total number of adults and children who initiated ART in the 12 months prior to the beginning of the reporting period, including those who have died, those who have stopped ART, and those lost to follow-up) 2017 8,963
TX_RET_den Aggregated Age/Sex: 15+ Female (Denominator: Total number of adults and children who initiated ART in the 12 months prior to the beginning of the reporting period, including those who have died, those who have stopped ART, and those lost to follow-up) 2017 170,223
TX_RET_den Aggregated Age/Sex: 15+ Male (Denominator: Total number of adults and children who initiated ART in the 12 months prior to the beginning of the reporting period, including those who have died, those who have stopped ART, and those lost to follow-up) 2017 109,917